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Background
Mechanical stress is a primary determinant of bone
growth and remodeling: weight bearing and locomotion
stimulate interstitial fluid flow through the bone canalic-
ular system, and the resultant shear stress is a major mech-
anism whereby mechanical forces stimulate bone growth
[1]. In response to fluid shear stress and other types of
mechanical stimulation, osteoblasts produce large
amounts of NO, and genetic and pharmacologic studies
indicate an important role of NO in osteoblast biology,
but little is known about signaling downstream of NO in
osteoblasts [1,2].
Results
In primary human osteoblasts and murine MC3T3-E1
cells, we found that fluid shear stress induced rapid
expression of c-fos, fra-1, fra-2, and fosB/ΔfosB  mRNAs;
these genes encode transcriptional regulators important
for osteoblast proliferation and differentiation, as demon-
strated by severe osteosclerotic or osteoporotic pheno-
types of mice that over-express or lack these proteins,
respectively. Fluid shear stress increased osteoblast nitric
oxide (NO) synthesis, leading to increased cGMP produc-
tion and activation of cGMP-dependent protein kinases
(PKG), as demonstrated by phosphorylation of the PKG I/
II substrate VASP. Pharmacological inhibition of the NO/
cGMP/PKG signaling pathway blocked shear-induced
expression of all four fos family genes. Induction of these
genes required signaling through MEK/Erk, and Erk acti-
vation was NO/cGMP/PKG-dependent. Treating cells with
a membrane-permeable cGMP analog partly mimicked
the effects of fluid shear stress on Erk activity and fos fam-
ily gene expression, and it appears that cGMP co-operates
with increased intracellular calcium in shear-stressed oste-
oblasts. In cells transfected with siRNAs specific for mem-
brane-bound PKG II, shear- and cGMP-induced Erk
activation and fos family gene expression was nearly abol-
ished and could be restored by transducing cells with a
virus encoding an siRNA-resistant form of PKG II; in con-
trast, siRNA-mediated repression of the more abundant
cytosolic PKG I isoform was without effect.
Conclusion
Thus, we report a novel function for PKG II in osteoblast
mechanotransduction, and propose a model whereby
NO/cGMP/PKG II-mediated Erk activation and induction
of c-fos, fra-1, fra-2, and fosB/ΔfosB play a key role in the
osteoblast anabolic response to mechanical stimulation.
Defective PKG II regulation of fos family transcription fac-
tors in osteoblasts may contribute to the developmental
bone defects observed in PKG II-deficient rodents [3].
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